Department of Anaesthesiology, University of Ulm, Prittwitzstraße 43, 89075 Ulm, Germany.
Br J Anaesth. 2011 Apr;106(4):580-9. doi: 10.1093/bja/aeq418. Epub 2011 Feb 3.
Thoracic epidural anaesthesia (EDA) is regarded as the 'gold standard' for postoperative pain control and restoration of pulmonary function after lung surgery. Easier, less time-consuming, and, perhaps, safer is intercostal nerve block performed under direct vision by the surgeon before closure of the thoracotomy combined with postoperative i.v. patient-controlled analgesia with morphine. We hypothesized that this technique is as effective as thoracic EDA.
The study was designed as a single-centre, open labelled, randomized non-inferiority trial. A total of 92 patients undergoing elective lung surgery were randomly assigned to the epidural (n=47) or intercostal group (n=45), and 83 patients completed the study. Pain scores, inspiratory vital capacity, forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and peak expiratory flow rate (PEFR) were assessed during the first four postoperative days.
Median treatment differences regarding pain scores at rest failed to demonstrate non-inferiority of the intercostal nerve block at the first postoperative day. Patients of the intercostal group reported significantly higher pain scores on coughing during the first and second postoperative days. The epidural group had a significantly higher median FVC, FEV1, and PEFR values on the second postoperative day. No difference was found in pulmonary complications, length of hospital stay, or in-hospital deaths.
In patients undergoing lung surgery, single intercostal nerve block plus i.v. patient-controlled analgesia with morphine is not as effective as patient-controlled EDA with respect to pain control and restoration of pulmonary function.
胸段硬膜外麻醉(EDA)被认为是肺手术后控制疼痛和恢复肺功能的“金标准”。在关胸前,由外科医生直视下进行肋间神经阻滞,并联合术后静脉患者自控镇痛(吗啡),操作更简单、耗时更少,且可能更安全。我们假设这种技术与胸段 EDA 同样有效。
该研究设计为单中心、开放标签、随机非劣效性试验。共 92 例行择期肺手术的患者被随机分配至硬膜外组(n=47)或肋间组(n=45),83 例患者完成了研究。在术后第 1 至 4 天评估疼痛评分、吸气肺活量、用力肺活量(FVC)、第 1 秒用力呼气量(FEV1)和呼气峰流速(PEFR)。
在术后第 1 天,关于静息时疼痛评分的中位数治疗差异未能证明肋间神经阻滞具有非劣效性。在术后第 1 和第 2 天,肋间组的患者在咳嗽时报告的疼痛评分显著更高。在术后第 2 天,硬膜外组的 FVC、FEV1 和 PEFR 中位数均更高。两组在肺部并发症、住院时间或院内死亡方面无差异。
在接受肺手术的患者中,与患者自控 EDA 相比,单次肋间神经阻滞联合静脉患者自控镇痛(吗啡)在控制疼痛和恢复肺功能方面效果不佳。